Results 261 to 270 of about 18,236,146 (293)

Galectin-3 as a cardiac biomarker

Clinica Chimica Acta
Galactoside-derived lectin galectin-3 (Gal-3) is an effective and promising cardiac fibrosis marker that can be used in heart failure management. Nevertheless, its clinical use demands strict standardization of preanalytical, analytical, and reporting methods.
Asif Ahmad, Bhat, Yahia, Alghazwani, Kumarappan, Chidambaram, M M, Rekha, Samir, Sahoo, Pavan, Goud, Nadeem, Sayyed, Vikas, Jakhmola, Moyad, Shahwan, Imran, Kazmi, Sami I, Alzarea, Omar Awad, Alsaidan   +11 more
openaire   +2 more sources

An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016–present)

Expert Opinion on Therapeutic Patents, 2021
Swetha Sanam, Aaftaab Sethi, Mallika Alvala   +2 more
exaly  

GALECTIN-3 INHIBITORS

2021
LIU CHUNJIAN, WANG WEI, ELLSWORTH BRUCE A, BALOG JAMES AARON, REGUEIRO-REN ALICIA   +4 more
openaire   +2 more sources

Galectin 3

1997
A. Neil Barclay, Marion H. Brown, S.K. Alex Law, Andrew J. McKnight, Michael G. Tomlinson, P. Anton van der Merwe   +5 more
openaire   +1 more source

Galectin 3

2000
Clare M. Isacke, Michael A. Horton
openaire   +1 more source

Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot

Reviews in Endocrine and Metabolic Disorders, 2022
Chunlan Zhang, Tian Li, Yang Xiao
exaly  

Galectin-3

2012
Rudolf Boer, Maxi Meissner, Dirk Veldhuisen   +2 more
openaire   +1 more source

Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance

Cell, 2016
Bing Cui, Wei Ying, Shuainan Liu
exaly  

Galectin-3 in cardiology

Klinická biochemie a metabolismus, 2022
A Jabor, J Franeková
openaire   +1 more source

Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z

International Journal of Molecular Sciences, 2018
Alberto Ricci, Luca Lavra, Salvatore Sciacchitano   +2 more
exaly